Medical News

RSS

Study: Healthy gut flora reduces risk of obesity and body's low-level inflammation

Poor gut flora is believed to trigger obesity. In the same way, healthy gut flora could reduce the risk. This has shown to be the case in tests on rats.

26 May 2011

Lx Therapies, BioCis partner to form Laurantis Pharma

BioCis Pharma Oy and Oy Lx Therapies Ltd. announced today that the companies have combined to create Laurantis Pharma Oy, a clinical-stage specialty pharmaceutical development company.

26 May 2011

Doctors and nurses key to preventing vaccine refusal outbreaks

Well-informed doctors and nurses are the key to preventing parents refusing childhood immunisations because of vaccine scare campaigns, a University of Sydney expert writes in the latest edition of the international journal Nature.

25 May 2011

Pulmonx announces new clinical data of Zephyr endobronchial valve in emphysema

Pulmonx Inc. has announced new clinical data from its Chartis multi-center study, presented at the American Thoracic Society's 2011 International Conference.

25 May 2011

Watson announces acquisition of Specifar Pharmaceuticals

Watson Pharmaceuticals, Inc. and Specifar Pharmaceuticals S.A. today jointly announced that Watson has acquired the privately-held multinational generic pharmaceutical developer, manufacturer and marketer for EUR 400 million in cash and certain contingent consideration.

25 May 2011

Scarcity of resources calls for equitable distribution system for novel HCV treatment

For many patients with the hepatitis C virus, direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, and with that clinicians must now decide who should be the first to receive this treatment.

25 May 2011

MAXIMUS offers eHealth Literacy Services for state and community programs

MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it is now offering eHealth Literacy Services to help state and community programs meet the communication and engagement challenges facing consumers and providers using the new health information technology infrastructure.

25 May 2011

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced today that new pre-clinical data for its novel, defensin-mimetic antimicrobial compounds was recently presented at two prestigious scientific meetings, including the American Society of Microbiology.

25 May 2011

Comtex SmarTrend ranks POZEN as second most efficient pharmaceutical company

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today that Comtex SmarTrend has ranked POZEN as the second most efficient company in the pharmaceutical industry.

25 May 2011

Akorn intends to offer $100M of Convertible Senior Notes due 2016

Akorn, Inc. announced today that, subject to market conditions, it intends to offer $100 million principal amount of Convertible Senior Notes due 2016.

25 May 2011

First Edition: May 25, 2011

Kaiser Health News staff writer Phil Galewitz reports: "Most Americans oppose the House Republicans' plan to overhaul and slash funding of Medicaid, the state-federal program that covers 56 million low-income people, according to a poll being released today".

25 May 2011

Medical Action fiscal 2011 fourth quarter net sales increase 48% to $105,273,000

Medical Action Industries Inc., a supplier of medical and surgical disposable products, today reported fourth quarter and fiscal 2011 results.

25 May 2011

Derma Sciences announces results of DSC127 Phase 2 trial in diabetic foot ulcers at 24-weeks

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.

25 May 2011

Apollo completes 100 liver transplantations in less than 4 years with over 90% success rate

Apollo centre for liver disease and transplantation has completed 100 liver transplantations in less than 4 years with over 90% success rate, creating a milestone in the history of medicine.

25 May 2011

CytoDyn announces additional funding to extend current 'Cytolin' study

CytoDyn Inc. announced that it is providing additional funding to extend the current study being conducted by Dr. Eric S. Rosenberg at Massachusetts General Hospital.

25 May 2011

Pathway receives FDA approval to commence PWT33597 Phase 1 study in advanced solid tumors

Pathway Therapeutics, Inc., a company developing novel therapeutics that target the PI3K and mTOR pathways, today announced that the FDA has accepted an IND filing for PWT33597, which allows Pathway to commence Phase 1 clinical testing.

25 May 2011

PPSC, InVivo enter sponsorship deal to support Adaptive Sailing Program for the disabled

InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that the Company has entered into a sponsorship agreement with Boston-based Piers Park Sailing Center to support a non-profit sailing initiative for the disabled.

25 May 2011

Medical News

Study: Healthy gut flora reduces risk of obesity and body's low-level inflammation

Lx Therapies, BioCis partner to form Laurantis Pharma

Doctors and nurses key to preventing vaccine refusal outbreaks

Pulmonx announces new clinical data of Zephyr endobronchial valve in emphysema

Watson announces acquisition of Specifar Pharmaceuticals

Scarcity of resources calls for equitable distribution system for novel HCV treatment

MAXIMUS offers eHealth Literacy Services for state and community programs

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

Comtex SmarTrend ranks POZEN as second most efficient pharmaceutical company

Akorn intends to offer $100M of Convertible Senior Notes due 2016

First Edition: May 25, 2011

Medical Action fiscal 2011 fourth quarter net sales increase 48% to $105,273,000

Derma Sciences announces results of DSC127 Phase 2 trial in diabetic foot ulcers at 24-weeks

Apollo completes 100 liver transplantations in less than 4 years with over 90% success rate

CytoDyn announces additional funding to extend current 'Cytolin' study

Pathway receives FDA approval to commence PWT33597 Phase 1 study in advanced solid tumors

PPSC, InVivo enter sponsorship deal to support Adaptive Sailing Program for the disabled

Avanafil phase 3 trial in ED following radical prostatectomy meets primary endpoints

Federal officials review Indiana's Planned Parenthood law

MKK4 enzyme may prevent arrhythmias linked with cardiac hypertrophy

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News